RI W AYAT JABATAN
A. PEN ULI S UTAM A/ PEM BI CARA ( D ALAM D AN LUAR N EGERI )
1. Abdul Majid: “Wanita dan Olahraga”. Dipersentasikan pada Ceramah Dharma Wanita PLN Sumatera Utara, 1 September 1983, Medan.
2. Abdul Majid: “Fisiologi Kelenjar Gondok”. Dipersentasikan pada KPPIK IV, FK-USU, 20-21 Agustus 1984, Medan.
3. Abdul Majid: “Membandingkan pengukuran kapasitas aerobic dengan steptest dan ergometer cycle”. Diperesentasikan pada Kongres ke-VI dan Seminar Nasional VIII IAIFI, 18-20 September 1986, Surabaya.
4. Abdul Majid: Distribusi Penderita Penyakit Paru yang berobat jalan di Poliklinik Pulmonologi Penyakit Dalam RS Pirngadi Medan, Diperesentasikan pada KOPAPDI VIII Yogyakarta, 24-30 Juni 1990. 5. Abdul Majid, Lukman Hakim Zain, Kariman Sudin, P. Tarigan: Satu
Kasus Malaria dengan Gejala Hepatitis, Naskah Lengkap KONAS PEGI dan PPHI, hal. 193-199, 28-30 November 1991, Medan.
6. Abdul Majid, Yasmeini Yazir: “Fisiologi Tubuh Normal Secara Umum.” Dipresentasikan pada Acara Ilmiah HUT FK-USU ke-42, 16 Agustus 1994, Medan.
7. Abdul Majid: “Diagnostik dan Pengobatan Infeksi Saluran Empedu”. Disajikan pada Pertemuan Ilmiah di RSU. Pertamina P. Brandan, 8 September 1994.
8. Abdul Majid: “Satu Kasus Duplikasi Pelvis Renis dan Ureter.” Dipresentasikan pada KONAS PERNEFRI 1995, Medan.
9. Abdul Majid: “Pengukuran dan Variasi Tekanan Darah”. Dimuat dalam Majalah Kedokteran Nusantara FK-USU ISSN 0216-325x, Vol.XXV No. 2 suppl.B, hal. 81-86,1995.
10. Abdul Majid: “Strategi Setelah Pengukuran Tekanan Darah”. Dimuat dalam, Majalah Kedokteraan Nusantara FK-USU, ISSN 0216-325x, Vol.XXV No. 2 suppl.B, hal. 24-30, 1995.
11. Abdul Majid: “Peranan Hormonal Dalam Metabolisme Calcium dan Fisiologi Tulang”. Dipresentasikan pada Ulang Tahun FK-USU ke-44, 1996, Medan.
12. Abdul Majid: “Penanggulangan Penyakit Infeksi dengan Antibiotika.” Dipresentasikan pada Siang Klinik Kalbe Farma, 26 Juni 1997, Medan.
13. Abdul Majid: “Blood pressure variability, is it important?” Dipresentasikan pada 11th
Asean Congress of Cardiology, July 1997, Jakarta.
14. Abdul Majid: “Hipertensi Primer: Ditinjau dari Aspek Patofisiologi.” Dipresentasikan pada RTD IDI Cabang Karo, 10 Juli 1997, RSU Kabanjahe.
15. Abdul Majid: “Dasar-Dasar Fisiologis Cairan Tubuh dan Elektrolit. Dipresentasikan pada Simposium Terapi Cairan Tubuh dan Elektrolit, HUT FK-USU ke-45, 18 Agustus 1997, Medan.
16. Abdul Majid, Yasmeiny Yazir: “Fisiologi Seksual Remaja.” Dipresentasikan pada Ceramah untuk Mahasiswa dan Remaja, HUT FK-USU ke-45, 18 November 1997, Medan.
17. Abdul Majid: “Fungsi Diastolik pada Pasien dengan Disfungsi Sistolik Ventrikel Kiri”. Dipersentasikan pada KOPAPDI ke-XI, 2000 Surabaya.
18. Abdul Majid, Alwi Idrus, Miftah R.: “Endokarditis Bakterial pada Pasien dengan Penyalahgunaan Obat”. Diperesentasikan pada Pertemuan Ilmiah Tahunan ke-1, Bagian Penyakit Dalam FK-USU,14 Januari 2000, Medan.
19. Abdul Majid: “Sindrom Koroner Akut: Diagnosis, Pengobatan dan Prevensi Sekunder.” Dipresentasikan pada BMS Scientific Meeting, 22 April 2000, Medan.
20. Abdul Majid: “ACE Inhibitor pada Pengobatan Hipertensi dan Gagal Jantung.” Dipresentasikan pada RS Caltex Scientific Meeting, RS Caltex P. Baru, 15 November 2000, Pekan Baru.
21. Abdul Majid: “The Importance of Diastolic Function in Normal and Pathologic Heart”. Dipresentasikan pada The Indonesia-Malaysia- Thailand Growth Triangle (IMT–GT) Research in Physiology, 2001. 22. Abdul Majid: “Current Concept Management of Heart Failure.”
Dipresentasikan pada Pertemuan Ilmiah RS Pertamina Rantau, 14 Februari 2001, P. Brandan.
23. Abdul Majid: “Management of Hypertension and Cardiovascular Risk Factor.” Dipresentasikan pada Pfizer Scientific Meeting, 25 Maret 2001, Prapat.
24. Abdul Majid: “Spectrum of Left Ventricular Diastolic Dysfunction in Normal and Abnormal Systolic Function”. Dipresentasikan pada 1st Asean Confrence on Medical Sciences, 18-21 Mei 2001, Kelantan, Malaysia.
25. Abdul Majid: “Left Ventricular Diastolic Dysfunction in Heart Filure with Systolic Dysfunction”. Dipresentasikan pada 13th Asian Pasific Congress of Cardiology, October 3-6, 2001. Mandaluyong City, Philippines.
26. Abdul Majid: “Peranan Ekokardiografi pada Gagal Jantung”. Dimuat dalam Majalah Kedokteran Nusantara FK-USU ISSN 0216-325x, Vol.34 No. 2, Hal. 94-97, Juni 2001.
27. Abdul Majid: ”Management of Cardiovascular risk factors: Hypertension in Elderly.” Dipresentasikan pada Servier Weekend Scientific Meeting, 14 Juli 2001, Medan.
28. Abdul Majid: “Hari Bebas Rokok Sedunia.” Dipresentasikan pada Ceramah Awam, RS Pertamina Rantau, 31 Juli 2001, P. Brandan. 29. Abdul Majid: “Management of Cardiovascular Risk Factor in
30. Abdul Majid: “Cara Membaca dan Interpretasi Electrocardiogram (ECG)”. Dipersentasikan pada Diklat Mahasiswa FK-USU, Pendidikan Kardiologi Umum dan Latihan Elektrokardiografi, 23 September 2001, Medan.
31. Abdul Majid: “The Benefits of Aggressive Reduction of LDL- Cholesterol in High Risk Patients”. Dipresentasikan pada Pfizer Scientific Meeting, 7 November 2001, Medan.
32. Abdul Majid: “Hypertension in the Older Person.” Dipresentasikan pada RS CALTEX Pakan Baru-Pfizer Scientific Meeting, 8 November 2001, Pekan Baru, Riau.
33. Abdul Majid: “Insight study: intervention as a goal in hypertension treatment”. Dipresentasikan pada Bayer Scientific Meeting, 10 November 2001, Sibayak Hotel Brastagi.
34. Abdul Majid: “The Role of Tissue ACE in Cardiovascular Disease.” Dipresentasikan pada Pfizer Scientific Meeting, 2 Maret 2002, Brastagi.
35. Abdul Majid: “Osteoporosis Detection and Treatment.” Dipresentasikan di RSU. Permata Bunda, 6 Maret 2002, Medan.
36. Abdul Majid: “Peranan Tissue ACE Pada Vaskular Sebagai Proteksi Disfungsi Endotel.” Dipresentasikan pada Pfizer-PAPDI Scientific Meeting, 16 Maret 2002, Medan.
37. Abdul Majid: “Recognizing and Treatment Peripheral Vascular Disease.” Dipresentasikan pada Otsuka Scientific Meeting, 20 Maret 2002, Medan.
38. Abdul Majid: “Seminar Sehari “Diagnosa Klinis dan Penatalaksanaan Penyakit Ginjal Hipertensi dan Kardiovaskular serta Nyeri Akut.” Dipresentasikan pada Servier–RS TNI AL Scientific Meeting, 23 Maret 2002, Tanjung Pinang.
39. Abdul Majid: “Systolic Hypertension in Elderly.” Dipresentasikan pada Pfizer Scientific Meeting, 17 April 2002, Medan.
40. Abdul Majid: “The Role of Statin in Acute Coronary Syndrome.” Dipresentasikan pada Pfizer Scientific Meeting, 20 April 2002, Medan.
41. Abdul Majid: “Osteoporosis Detection and Treatment.” Dipresentasikan pada Aventis Scientific Meeting, 24 April 2002, Medan.
42. Abdul Majid: “Extending the benefits neuro hormonal antagonism”. Dipresentasikan pada PT Novell Scientific Meeting, 7 Mei 2002, Medan.
43. Abdul Majid: “Practice Guideline for the Management of Hypertension.” Dipresentasikan pada Servier-RS Pertamina Brandan Scientific Meeting, 15 Mei 2002, RS Pertamina P. Brandan.
44. Abdul Majid: “Insight Study: Intervention as a Goal in Hypertensive Treatment.” Dipresentasikan pada Bayer Scientific Meeting, 18 Mei 2002, Brastagi.
45. Abdul Majid: “The Role ACE-I in Cardiocerebrovascular Protection: Focus on Progress Study.” Dipresentasikan pada Servier Scientific Meeting, 26 Mei 2002, Songkla Hadyai, Thailand.
46. Abdul Majid: “Osteoporosis: Detection and Management”. Dipresentasikan pada PT Aventis Pharma–IDI cab. Kabupaten Asahan scientific meeting, 29 Mei 2002, Kisaran.
47. Abdul Majid: “Statin in Acute Coronary Syndrome, Start from the Hospital?” Dipresentasikan pada Pfizer Scientific Meeting, 1 Juni 2002, Brastagi.
48. Abdul Majid: “Acute Coronary Syndrome.” Dipresentasikan pada Pfizer Scientific Meeting, 1 Juni 2002, Brastagi.
49. Abdul Majid: “Penatalaksanaan Hipertensi dan Cardiovascular Disease dengan Carvedilol”, Dipresentasikan pada PT. Roche Indonesia, 15 Juni 2002, Hotel Grand Angkasa Medan.
50. Abdul Majid: “Perkembangan Baru Pengobatan Hipertensi dan Penyakit Jantung Iskemik.” Dipresentasikan pada Tanabe Scientific Meeting, 25 Juni 2002, Pematang Siantar.
51. Abdul Majid: “Penatalaksanaan Dislipidemia”. Dipresentasikan pada acara siang klinik PT. Novartis Biochemie, 7-8 Juli 2002, Duri & Rumbai.
52. Abdul Majid: “Management of Dyslipidemia in Cardiovascular Disease: An Update.” Dipresentasikan pada Novartis Scientific Meeting, 13 Juli 2002, Brastagi.
53. Abdul Majid: ”The Management of Hypertension on Diabetic with Indapamide SR.” Dipresentasikan pada Servier Scientific Meeting, 27 Juli 2002, Brastagi.
54. Abdul Majid: “Penatalaksanaan Pasien Resiko tinggi Kardiovaskular dan Komplikasinya.” Dipresentasikan pada Aventis Scientific Meeting, 5 Agustus 2002, Medan.
55. Abdul Majid: “Combating the risk factors of cardiovascular diseases: Management of dyslipidemia an update”. Dipresentasikan pada Pfizer Scientific Meeting, 17 September 2002, Pematang Siantar. 56. Abdul Majid: “New Guideline in the Management of Hypertension
and Heart Failure. Focus on ACE Inhibitor.” Dipresentasikan Tanabe Scientific Meeting, 26 September 2002, Medan.
57. Abdul Majid: “Practice Guideline in the Management of Hypertension.” Dipresentasikan pada Pfizer Scientific Meeting, 25
58. Abdul Majid: “Current and Future Options in the Management of Dyslipidemia.” Dipresentasikan pada Pfizer Scientific Meeting, 12 Oktober 2002, Prapat.
59. Abdul Majid: “Comparison of AIIRA and ACE Inhibitor in Management of Hypertension.” Dipresentasikan pada Takeda Scientific Meeting, 13 Oktober 2002, Brastagi.
60. Abdul Majid: “Endothelial dysfunction; Focus in Quinapril.” Dipresentasikan pada Pfizer Scientific Meeting, 19 Oktober 2002, Brastagi.
61. Abdul Majid: “A New Progress in Secondary Stroke Prevention.” Dipresentasikan pada Servier Scientific Meeting, 20 Oktober 2002, Medan.
62. Abdul Majid: “The Role of ACE Inhibitor in 24 Hours Blood Presure Control and Cardiocerebrovascular Protection.” Dipresentasikan pada Servier-IDI Cab. Karo Scientific Meeting, 6 November 2002, Kabanjahe.
63. Abdul Majid: “Management of Hypertension.” Dipresentasikan pada Novartis Scientific Meeting, 6 Maret 2003, Medan.
64. Abdul Majid: “Peranan tissue ACE pada disfungsi endotel vaskuler”. Dipresentasikan pada Rapat Anggota PAPDI cabang Sumatera Utara, 16 Maret 2003, Medan.
65. Abdul Majid: “Endothelium: New Target Organ for Therapy.” Dipresentasikan pada Pfizer Scientific Meeting, Medan, 19 Maret 2003.
66. Abdul Majid: “How to Manage Hypertension in Elderly Patients?” Dipresentasikan pada Takeda Scientific Meeting, Brastagi, 22 Maret 2003.
67. Abdul Majid: “Role of Rosuvastatin in Atherosclerosis and Metabolic Disease.” Dipresentasikan pada Astra Zeneca Scientific Meeting, 24 Maret 2003, Medan.
68. Abdul Majid: “Management of dyslipidemia in cardiovascular diseases: An update”. Dipresentasikan pada IDI Siantar – Novartis Scientific Meeting, 25 Maret 2003, P. Siantar.
69. Abdul Majid: “The Management of Hypertension with Diabetes”. Dipresentasikan pada: Sanofi Scientific Meeting, 27 April 2003, Medan.
70. Abdul Majid: “New Stepwise Approach to Preoperative Cardiac Assesment: Focus on Decrease study.” Dipresentasikan pada Merck- RSU Permata Bunda Scientific Meeting, 29 Mei 2003, Medan. 71. Abdul Majid: “Update on the Management of Hypertension.”
Dipresentasikan pada Servier-Pertamina P. Susu Scientific Meeting, 31 Mei 2003, Brastagi.
72. Abdul Majid: “Expanding Horizon of Cardiac Care, the Role of Co- Q10.” Dipresentasikan pada Mega Scientific Meeting, 21 Juni 2003, Medan.
73. Abdul Majid: “Combination Therapy on Hypertension.” Dipresentasikan pada Sanofi-Synthelabo Scientific Meeting, 26 Juli 2003, Medan.
74. Abdul Majid: “New Challenges in Treating Hypertension: Rationale for Drug Combination Therapy”. Dipresentasikan pada Sanofi Scientific Meeting, 6 Agustus 2003, Brastagi.
75. Abdul Majid: ”Management of Coronary Artery Disease: Focus on EUROPA”, Servier Scientific Meeting, 20 Januari 2004.
76. Abdul Majid: Kursus EKG FK-USU, Februari 2004.
77. Abdul Majid: “New Tactics, New Targets: the Changing Landscape of Dyslipidemia Management in Coronary Prevention”, Astra Zeneca Scientific Meeting, Brastagi, 7 Februari 2004.
78. Abdul Majid: ”Management of Coronary Artery Disease: Focus on EUROPA”, Servier scientific meeting, 19 Februari 2004.
79. Abdul Majid: “New Strategies in Coronary Prevention Focus in Hs CRP”. Dipresentasikan pada: Symposium Hs CRP: What are The Implication for Clinical Practice? Pertemuan Ilmiah UPIM FK-USU, Medan, 21 Februari 2004.
80. Abdul Majid: “Tight Blood Presure Controle and Lipid Management: the Early Prevention of Stroke and Heart Attacks-Recent Evidence”, Dipresentasikan pada: Pfizer Scientific Meeting Brastagi, 13 Maret 2004.
81. Abdul Majid: “Lipid Management to Prevent Cardiovascular Events”, Dipresentasikan pada: Pfizer Scientific Meeting Brastagi, 14 Maret 2004.
82. Abdul Majid: “Management of Dyslipidemia in Cardiovascular Disease.” Dipresentasikan pada: Novartis Scientific Meeting Medan, 27 Maret 2004.
83. Abdul Majid: “Clinical Practice Fluid Therapy in Internal Medicine”. Dipresentasikan pada: Otsuka-SMF Penyakit Dalam RSPM Scientific Meeting Medan, 8 April 2004.
84. Abdul Majid: “Tekanan darah tinggi gejala dan penanggulangannya”. Dipresentasikan pada: Temu Ilmiah Kesehatan YAKES Telkom Medan, 13 April 2004.
85. Abdul Majid: “New frontiers in hypertension management: Focus on Lercadipine”. Dipresentasikan pada: Fournier Pharma Indonesia– Pertamina Medan Scientific Meeting Medan, 14 April 2004.
86. Abdul Majid: “Management of dyslipidemia to prevent cardiovascular events: The role of fenofibrate supra”. Dipresentasikan pada: Fournier Pharma Indonesia–Pertamina Medan Scientific Meeting Medan, 14 April 2004.
87. Abdul Majid: “Diuretic Therapy in Heart Failure Focus on LASIX”. Dipresentasikan pada: Aventis Scientific Meeting P. Susu, 21 April 2004.
88. Abdul Majid: ”The role of statin in the management of coronary artery disease: An Update”, BMS scientific meeting, 1 Mei 2004.
89. Abdul Majid: “Metabolic syndrome as CHD Risk Factor“. Dipresentasikan pada: Fournier Pharma Indonesia Symposium Medan, 15 Mei 2004.
90. Abdul Majid: “Special situations in hypertension management: Hypertensive crises”, Yamanouchi–SMF Penyakit Dalam RS Pirngadi Medan Scientific meeting, 19 Mei 2004.
91. Abdul Majid: “Therapeutic strategies of hypertension: Implication of JNC 7 2003 & ESH-ESC Guidelines 2003, Rationale for Drug Combination Therapy”, Merck Scientific Meeting, 5 Juni 2004.
92. Abdul Majid: “Diuretic therapy in heart failure: Focus on LASIX”, Aventis Scientific Meeting, 19 Juni 2004.
93. Abdul Majid: “Management of Coronary Artery Disease”. Dipresentasikan pada: Servier–Pertamina Scientific Meeting, 27 Juni 2004.
94. Abdul Majid: ”Cholesterol Independent Effects of Statin: Benefits of Plelotropic Effects”, Pfizer scientific meeting, 24 Juli 2004.
95. Abdul Majid: Latest Management of Hypertension: Rationale for Drug Combination Therapy”, Takeda Scientific Meeting, 14 Agustus 2004.
96. Abdul Majid: “Cardiovascular Aspects of Erectile Dysfunction (ED) Focus on Tadalafil (Cialis)”. Dipresentasikan pada: Symposium Paradigma Baru Pengobatan Disfungsi Ereksi Terkini, P. Siantar, 9 September 2004.
97. Abdul Majid: “Hypertension and LVH.” Dipresentasikan pada Sanofi Scientific Meeting, 23 September 2004, Medan.
98. Abdul Majid: “Profil Diastolik Ventrikel Kiri secara Ekokardiografi pada Gagal Jantung Kongestif”. Dimuat dalam: Majalah Kedokteran Nusantara (The Journal of Medical School University of Sumatera Utara), ISSN 0216-325x, Vol. 38 No. 1, hal. 5-10, Maret 2005.
99. Abdul Majid: “Prevensi Endokarditis Bacterial”. Dimuat dalam: Majalah Kedokteran Nusantara (The Journal of Medical School University of Sumatera Utara), ISSN 0216-325x, Vol. 38 No. 1, hal. 39-41, Maret 2005.
100.Abdul Majid: “Penanganan Heart Failure.” Dipresentasikan pada Aventis-Pertamina P. Susu Scientific Meeting, 14 April 2005, P. Susu.
101.Abdul Majid: “The Management of High Risk Patient: Focus on Ramipril”. Dipresentasikan pada Sanofi-Aventis Scientific Meeting Brastagi, 7 Mei 2005.
102.Abdul Majid: “Intravenous Nicardipine for the Treatment of Crisis Hypertension”, dipresentasikan dalam: 4th Asian-Pasific Congress of Hypertension, Korea, 1-4 June 2005.
103.Abdul Majid: ”High risk patients: How to manage?” The Role of Ramipril. Aventis–RSU. Rantau Prapat, Scientific Meeting, 29 Juni 2005.
104.Abdul Majid: “Terapi Cairan untuk Pasien Rawat Inap”. Dipresentasikan pada: Otsuka–RSU L. Pakam Scientific Meeting Lubuk Pakam, 30 Juni 2005.
105.Abdul Majid: “How Do We Treat Metabolic Syndrome”. Dipresentasikan pada: Fournier Pharma Indonesia Launching Symposium Medan, 9 Juli 2005.
106.Abdul Majid: Peripheral Vascular Disease: Recognizing and Treatment”, P. Siantar, 4 Agustus 2005.
107.Abdul Majid: ”Angiotensin II Receptor Blockers in Chronic Heart Failure.” Dipresentasikan pada Takeda Scientific Meeting, 6 Agustus 2005, Medan.
108.Abdul Majid: “ARBs in Heart Failure”. Dipresentasikan pada: Takeda Scientific Meeting, 25 Agustus 2005, Medan.
109.Abdul Majid: “Pleiotropic Effects of Statin: Beyond Lipid-Lowering Properties.” Dipresentasikan pada Pfizer Scientific Meeting, 10 September 2005, Medan.
110.Abdul Majid: “The Emerging Role of ARBs in The Management of Cardiovascular Disease: Current Issues.” Dipresentasikan pada Novartis Scientific Meeting, 27 September 2005, Medan.
111.Abdul Majid: “Management of Coronary Artery Disease”. Dipresentasikan pada Bayer Scientific Meeting Medan, 22 September 2005.
112.Abdul Majid: “Clinical Practice Heart Failure Management”. Dipresentasikan pada Takeda Scientific Meeting Medan, 1 Oktober 2005.
113.Abdul Majid: “Management of Hypertension: Focus on Olmesartan”. Dipresentasikan pada Pfizer Scientific Meeting, 28 Desember 2005., Medan.
114.Abdul Majid: “ARB in the Management of Hypertension: Focus on Olmesartan. The newest ARBs with superior efficacy in achieving BP Goal.” Dipresentasikan pada Pfizer Scientific Meeting, 25 Februari 2006, P. Siantar.
115.Abdul Majid: “What’s New Managing Hypertensive Patient at High Risk”. Dipersentasikan pada 15th Annual Scientific Meeting of The Indonesian Heart Association (ASMIHA), Medan, 19-22 April 2006. 116.Abdul Majid: “Current diagnosis and management of hypertension
and heart failure”, Aventis–CALTEX Rumbai–Duri Scientific Meeting, 26-27 April 2006.
117.Abdul Majid: “Bridging the Gap in Lipid Management.” Dipresentasikan pada Merck Scientific Meeting, 20 Mei 2006, Medan.
118.Abdul Majid: “The Benefit Effect of ARB in Vascular and Renal Protection, Focus on Olmesartan”. Dipersentasikan pada: Symposium New Approach in Hypertension Medan, HUT FK-USU 54, 24 Juni 2006.
119.Abdul Majid: “Homocycteine as a CVD Risk Factor.” Dipresentasikan pada UAP Scientific Meeting, 15 Juli 2006, Medan.
120.Abdul Majid: “New Aproach in Hypertension Management.” Dipresentasikan pada Pfizer Scientific Meeting, 26 Juli 2006, RS Pertamina, P. Brandan.
121.Abdul Majid: “What’s New in Managing Hypertensive Patient at High Risk Action Study: Advantages of Nifedipine GITS for Hypertensive patients.” Dipresentasikan pada Bayer Scientific Meeting, 16 Agustus 2006, Medan.
122.Abdul Majid: “Latest Management of Hypertension: Rationale for Drug Combination Therapy.” Dipresentasikan pada Takeda Scientific Meeting, 16 September 2006, Brastagi.
123.Abdul Majid: “The Latest Breaking Clinical Trial for AMI: Focus on CLARITY & COMMIT Results”. Dipresentasikan pada Sanofi Aventis Scientific Meeting, 14 November 2006, Medan.
124.Abdul Majid: “How to Choose anti Hypertensive Drugs?” Dipresentasikan pada Sandoz Scientific Meeting, 20 Desember 2006, Kisaran.
125.Abdul Majid: “What’s New in Managing Hypertensive Patient at High Risk Action Study: Avantages of Nifedipine GITS for Hypertensive patients.” Dipresentasikan pada Bayer Scientific Meeting, 25 Januari 2007, Medan.
126.Abdul Majid: “Syok Kardiogenik”. Dipersentasikan pada Workshop Syok, PIT Penyakit Dalam, FK-USU, 7 Maret 2007, Medan.
127.Abdul Majid: “Role of Rosuvastatin in Atherosclerosis and Metabolic Disease”, Astra Zeneca Scientific Meeting, 24 Maret 2007.
128.Abdul Majid: “How to Choose Anti Hypertensive Drugs”. Dipresentasikan pada ACTAVIS Scientific Meeting, 22 April 2007, Medan.
129.Abdul Majid: “Hypertension Management to Improve Cardiovascular Outcomes:” Taking ACTION Putting the Result into Context”.
Symposium NTCM 4,15 Juni 2007 Medan.
130.Abdul Majid:Latest Management of Hypertension: Rationale for Drug Combination, TAKEDA Scientific meeting 23-06-2007, P. Siantar.